The Mark Cuban Cost Plus Drug Company negotiates directly with drugmakers.
So far, that's been the strategy for the Mark Cuban Cost Plus Drug Company.
In October, Cost Plus Drug Company announced a partnership with Capital Blue Cross.
Cuban said he wanted Cost Plus Drug Company to be as transparent as possible on pricing.
Cost Plus Drug Company is considering a test program for insulin that would offer a 90-day supply of insulin, or a total of 12 vials, for $170.